_id
6915f517bc934aba376b2313
Ticker
SCNI
Name
Scinai Immunotherapeutics Ltd
Exchange
NASDAQ
Address
Jerusalem BioPark, Jerusalem, Israel
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.scinai.com
Description
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Last Close
0.7298
Volume
12709
Current Price
0.9092
Change
0.0214
Last Updated
2026-01-06T10:51:58.800Z
Image
data:image/webp;base64,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
Ipo Date
2015-05-12T00:00:00.000Z
Market Cap
2325411
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
5
Target Price
700
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
277290
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1240776
Operating Income
-963485
Interest Expense
-
Pretax Income
-
Net Income
-2119868
Eps
-1.332259080193793
Dividends Per Share
-
Shares Outstanding
3187679
Income Tax Expense
-
EBITDA
-963485
Operating Margin
-347.4647480976595
Total Other Income Expense Net
963485
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
0.1824
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
39
Deep Value Investing Score
2.5
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
277290
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1240776
Quarters > 0 > income Statement > operating Income
-963485
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-2119868
Quarters > 0 > income Statement > eps
-1.332259080193793
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1591183
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-963485
Quarters > 0 > income Statement > operating Margin
-347.4647480976595
Quarters > 0 > income Statement > total Other Income Expense Net
963485
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-1.332259080193793
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
386500
Quarters > 1 > income Statement > cost Of Revenue
1021500
Quarters > 1 > income Statement > gross Profit
-635000
Quarters > 1 > income Statement > operating Expenses
1246500
Quarters > 1 > income Statement > operating Income
-1881500
Quarters > 1 > income Statement > interest Expense
185500
Quarters > 1 > income Statement > pretax Income
-2067000
Quarters > 1 > income Statement > net Income
-2067000
Quarters > 1 > income Statement > eps
-1.2990334864060262
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1591183
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1529500
Quarters > 1 > income Statement > operating Margin
-486.8046571798189
Quarters > 1 > income Statement > total Other Income Expense Net
-185500
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
989000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
139000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1506000
Quarters > 1 > balance Sheet > property Plant Equipment
10334000
Quarters > 1 > balance Sheet > total Assets
11840000
Quarters > 1 > balance Sheet > payables
659000
Quarters > 1 > balance Sheet > short Term Debt
497000
Quarters > 1 > balance Sheet > long Term Debt
293000
Quarters > 1 > balance Sheet > total Liabilities
3982000
Quarters > 1 > balance Sheet > equity
7858000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2067000
Quarters > 1 > cash Flow > depreciation
352000
Quarters > 1 > cash Flow > change In Working Capital
134500
Quarters > 1 > cash Flow > cash From Operations
-1287500
Quarters > 1 > cash Flow > capital Expenditures
6000
Quarters > 1 > cash Flow > cash From Investing
-6000
Quarters > 1 > cash Flow > cash From Financing
790500
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.2990334864060262
Quarters > 1 > ratios > PB
0.18410582636803258
Quarters > 1 > ratios > ROE
-26.304403156019347
Quarters > 1 > ratios > ROA
-17.45777027027027
Quarters > 1 > ratios > FCF
-1293500
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-3.346701164294955
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
386500
Quarters > 2 > income Statement > cost Of Revenue
1021500
Quarters > 2 > income Statement > gross Profit
-635000
Quarters > 2 > income Statement > operating Expenses
1787000
Quarters > 2 > income Statement > operating Income
-1881500
Quarters > 2 > income Statement > interest Expense
10942
Quarters > 2 > income Statement > pretax Income
-2067000
Quarters > 2 > income Statement > net Income
-1549000
Quarters > 2 > income Statement > eps
-1.920959165046232
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
806368
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-841000
Quarters > 2 > income Statement > operating Margin
-486.8046571798189
Quarters > 2 > income Statement > total Other Income Expense Net
-185500
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
989000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
139000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1506000
Quarters > 2 > balance Sheet > property Plant Equipment
10334000
Quarters > 2 > balance Sheet > total Assets
11840000
Quarters > 2 > balance Sheet > payables
659000
Quarters > 2 > balance Sheet > short Term Debt
497000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3982000
Quarters > 2 > balance Sheet > equity
7858000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-2067000
Quarters > 2 > cash Flow > depreciation
352000
Quarters > 2 > cash Flow > change In Working Capital
134500
Quarters > 2 > cash Flow > cash From Operations
-1287500
Quarters > 2 > cash Flow > capital Expenditures
6000
Quarters > 2 > cash Flow > cash From Investing
-6000
Quarters > 2 > cash Flow > cash From Financing
790500
Quarters > 2 > cash Flow > net Change In Cash
-2095000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-1.920959165046232
Quarters > 2 > ratios > PB
0.09329979455332146
Quarters > 2 > ratios > ROE
-19.712395011453296
Quarters > 2 > ratios > ROA
-13.082770270270268
Quarters > 2 > ratios > FCF
-1293500
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-3.346701164294955
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
206000
Quarters > 3 > income Statement > cost Of Revenue
373000
Quarters > 3 > income Statement > gross Profit
-167000
Quarters > 3 > income Statement > operating Expenses
2469000
Quarters > 3 > income Statement > operating Income
-2263000
Quarters > 3 > income Statement > interest Expense
37000
Quarters > 3 > income Statement > pretax Income
-2203000
Quarters > 3 > income Statement > net Income
-2230000
Quarters > 3 > income Statement > eps
-0.0006535787600084772
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3411983584
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-1098.5436893203885
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1964000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
83000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2391000
Quarters > 3 > balance Sheet > property Plant Equipment
11057000
Quarters > 3 > balance Sheet > total Assets
13448000
Quarters > 3 > balance Sheet > payables
376000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
260000
Quarters > 3 > balance Sheet > total Liabilities
3471000
Quarters > 3 > balance Sheet > equity
9977000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2230000
Quarters > 3 > cash Flow > depreciation
499000
Quarters > 3 > cash Flow > change In Working Capital
475000
Quarters > 3 > cash Flow > cash From Operations
-1076000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2000000
Quarters > 3 > cash Flow > net Change In Cash
926000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.0006535787600084772
Quarters > 3 > ratios > PB
310.9326926503758
Quarters > 3 > ratios > ROE
-22.35140823894958
Quarters > 3 > ratios > ROA
-16.582391433670434
Quarters > 3 > ratios > FCF
-1076000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-5.223300970873787
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
658000
Annuals > 0 > income Statement > cost Of Revenue
1238000
Annuals > 0 > income Statement > gross Profit
-580000
Annuals > 0 > income Statement > operating Expenses
8058000
Annuals > 0 > income Statement > operating Income
-8638000
Annuals > 0 > income Statement > interest Expense
1438796
Annuals > 0 > income Statement > pretax Income
4796000
Annuals > 0 > income Statement > net Income
4796000
Annuals > 0 > income Statement > eps
5.947656653041787
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
806368
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-6989000
Annuals > 0 > income Statement > operating Margin
-1312.7659574468084
Annuals > 0 > income Statement > total Other Income Expense Net
13434000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1964000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
217000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2391000
Annuals > 0 > balance Sheet > property Plant Equipment
11057000
Annuals > 0 > balance Sheet > total Assets
13448000
Annuals > 0 > balance Sheet > payables
376000
Annuals > 0 > balance Sheet > short Term Debt
424000
Annuals > 0 > balance Sheet > long Term Debt
260000
Annuals > 0 > balance Sheet > total Liabilities
3471000
Annuals > 0 > balance Sheet > equity
9977000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
4796000
Annuals > 0 > cash Flow > depreciation
1649000
Annuals > 0 > cash Flow > change In Working Capital
112000
Annuals > 0 > cash Flow > cash From Operations
-6335000
Annuals > 0 > cash Flow > capital Expenditures
12000
Annuals > 0 > cash Flow > cash From Investing
-12000
Annuals > 0 > cash Flow > cash From Financing
3441000
Annuals > 0 > cash Flow > net Change In Cash
-2915000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
5.947656653041787
Annuals > 0 > ratios > PB
0.06068975956700411
Annuals > 0 > ratios > ROE
48.070562293274534
Annuals > 0 > ratios > ROA
35.663295657346815
Annuals > 0 > ratios > FCF
-6347000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-9.645896656534955
Annuals > 0 > health Score
73
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
512675
Annuals > 1 > income Statement > gross Profit
-512675
Annuals > 1 > income Statement > operating Expenses
9706000
Annuals > 1 > income Statement > operating Income
-9706000
Annuals > 1 > income Statement > interest Expense
7979
Annuals > 1 > income Statement > pretax Income
-6500000
Annuals > 1 > income Statement > net Income
-6500000
Annuals > 1 > income Statement > eps
-16.63863696286
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
390657
Annuals > 1 > income Statement > income Tax Expense
0.28
Annuals > 1 > income Statement > EBITDA
-9192000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
3215000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4870000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
330000
Annuals > 1 > balance Sheet > inventories
-366000
Annuals > 1 > balance Sheet > total Current Assets
5447000
Annuals > 1 > balance Sheet > property Plant Equipment
12025000
Annuals > 1 > balance Sheet > total Assets
17472000
Annuals > 1 > balance Sheet > payables
535000
Annuals > 1 > balance Sheet > short Term Debt
792000
Annuals > 1 > balance Sheet > long Term Debt
19368000
Annuals > 1 > balance Sheet > total Liabilities
22041000
Annuals > 1 > balance Sheet > equity
-4569000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6500000
Annuals > 1 > cash Flow > depreciation
514000
Annuals > 1 > cash Flow > change In Working Capital
-646000
Annuals > 1 > cash Flow > cash From Operations
-9382000
Annuals > 1 > cash Flow > capital Expenditures
637000
Annuals > 1 > cash Flow > cash From Investing
-637000
Annuals > 1 > cash Flow > cash From Financing
1086000
Annuals > 1 > cash Flow > net Change In Cash
-9205000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-16.63863696286
Annuals > 1 > ratios > PB
-0.06420318260013132
Annuals > 1 > ratios > ROE
142.26307725979424
Annuals > 1 > ratios > ROA
-37.202380952380956
Annuals > 1 > ratios > FCF
-10019000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
559801
Annuals > 2 > income Statement > gross Profit
-559801
Annuals > 2 > income Statement > operating Expenses
11061000
Annuals > 2 > income Statement > operating Income
-11061000
Annuals > 2 > income Statement > interest Expense
5047000
Annuals > 2 > income Statement > pretax Income
-5796000
Annuals > 2 > income Statement > net Income
-5796000
Annuals > 2 > income Statement > eps
-30.74491165346729
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
188519
Annuals > 2 > income Statement > income Tax Expense
333515
Annuals > 2 > income Statement > EBITDA
-10499000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5265000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
14075000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
110000
Annuals > 2 > balance Sheet > inventories
-852279
Annuals > 2 > balance Sheet > total Current Assets
14370000
Annuals > 2 > balance Sheet > property Plant Equipment
12697000
Annuals > 2 > balance Sheet > total Assets
27067000
Annuals > 2 > balance Sheet > payables
716000
Annuals > 2 > balance Sheet > short Term Debt
382000
Annuals > 2 > balance Sheet > long Term Debt
20082000
Annuals > 2 > balance Sheet > total Liabilities
28827000
Annuals > 2 > balance Sheet > equity
-1760000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5796000
Annuals > 2 > cash Flow > depreciation
562000
Annuals > 2 > cash Flow > change In Working Capital
446000
Annuals > 2 > cash Flow > cash From Operations
-7265000
Annuals > 2 > cash Flow > capital Expenditures
836000
Annuals > 2 > cash Flow > cash From Investing
-836000
Annuals > 2 > cash Flow > cash From Financing
6776000
Annuals > 2 > cash Flow > net Change In Cash
-3302000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-30.74491165346729
Annuals > 2 > ratios > PB
-0.08043120289772727
Annuals > 2 > ratios > ROE
329.3181818181818
Annuals > 2 > ratios > ROA
-21.413529390032142
Annuals > 2 > ratios > FCF
-8101000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
747649
Annuals > 3 > income Statement > gross Profit
-747649
Annuals > 3 > income Statement > operating Expenses
10862000
Annuals > 3 > income Statement > operating Income
-10874000
Annuals > 3 > income Statement > interest Expense
3363649
Annuals > 3 > income Statement > pretax Income
-8206000
Annuals > 3 > income Statement > net Income
-8206000
Annuals > 3 > income Statement > eps
-58.13920535056396
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
141144
Annuals > 3 > income Statement > income Tax Expense
3481058
Annuals > 3 > income Statement > EBITDA
-10391000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
2668000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
17374000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
325151
Annuals > 3 > balance Sheet > inventories
-240848.28
Annuals > 3 > balance Sheet > total Current Assets
17843000
Annuals > 3 > balance Sheet > property Plant Equipment
14193000
Annuals > 3 > balance Sheet > total Assets
32036000
Annuals > 3 > balance Sheet > payables
999000
Annuals > 3 > balance Sheet > short Term Debt
623361
Annuals > 3 > balance Sheet > long Term Debt
63252000
Annuals > 3 > balance Sheet > total Liabilities
31054000
Annuals > 3 > balance Sheet > equity
982000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-8206000
Annuals > 3 > cash Flow > depreciation
471000
Annuals > 3 > cash Flow > change In Working Capital
701000
Annuals > 3 > cash Flow > cash From Operations
-7426000
Annuals > 3 > cash Flow > capital Expenditures
133122
Annuals > 3 > cash Flow > cash From Investing
-139000
Annuals > 3 > cash Flow > cash From Financing
21430000
Annuals > 3 > cash Flow > net Change In Cash
14440000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-58.13920535056396
Annuals > 3 > ratios > PB
0.10792772871690427
Annuals > 3 > ratios > ROE
-835.6415478615071
Annuals > 3 > ratios > ROA
-25.61493320014983
Annuals > 3 > ratios > FCF
-7559122
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
15
Valuation > metrics > PE
0.1824
Valuation > final Score
70
Valuation > verdict
98.2% Undervalued
Profitability > metrics > Net Margin
-7.6449493310252805
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1
Risk > final Score
26
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
7
Prev Risks > 1
-640
Prev Risks > 2
-185
Prev Liquidities > 0
83
Prev Liquidities > 1
83
Prev Liquidities > 2
100
Updated At
2026-01-20T22:32:20.936Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-02
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.6
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-2.6
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-05-07
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
4.31
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
4.31
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-02-26
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.6351
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-22
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
12.39
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-07-02
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4.3096
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-15
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.47
Earnings History > 5 > eps Estimate
-0.62
Earnings History > 5 > eps Difference
0.15
Earnings History > 5 > surprise Percent
24.1935
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2023-12-31
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-24
Earnings History > 6 > eps Estimate
-6.2
Earnings History > 6 > eps Difference
-17.8
Earnings History > 6 > surprise Percent
-287.0968
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-10-31
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.8
Earnings History > 7 > eps Estimate
-0.99
Earnings History > 7 > eps Difference
1.79
Earnings History > 7 > surprise Percent
180.8081
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-08-11
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.11
Earnings History > 8 > eps Estimate
-0.91
Earnings History > 8 > eps Difference
-0.2
Earnings History > 8 > surprise Percent
-21.978
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-05-02
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.09
Earnings History > 9 > eps Estimate
-0.1
Earnings History > 9 > eps Difference
-0.99
Earnings History > 9 > surprise Percent
-990
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-30
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.0029
Earnings History > 10 > eps Estimate
-0.1
Earnings History > 10 > eps Difference
0.1029
Earnings History > 10 > surprise Percent
102.9
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-25
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0061
Earnings History > 11 > eps Estimate
-0.01
Earnings History > 11 > eps Difference
0.0039
Earnings History > 11 > surprise Percent
39
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-06-01
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.005
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-03-28
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.01
Earnings History > 13 > eps Estimate
-0.16
Earnings History > 13 > eps Difference
0.17
Earnings History > 13 > surprise Percent
106.25
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-11-30
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0063
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-08-26
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0093
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-05-13
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.14
Earnings History > 16 > eps Estimate
-0.01
Earnings History > 16 > eps Difference
-1.13
Earnings History > 16 > surprise Percent
-11300
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2021-01-28
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.0305
Earnings History > 17 > eps Estimate
-0.01
Earnings History > 17 > eps Difference
0.0405
Earnings History > 17 > surprise Percent
405
Earnings History > 18 > period
2020-06-30
Earnings History > 18 > report Date
2020-08-20
Earnings History > 18 > date
2020-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.1
Earnings History > 18 > eps Estimate
-0.01
Earnings History > 18 > eps Difference
-0.09
Earnings History > 18 > surprise Percent
-900
Earnings History > 19 > period
2020-03-31
Earnings History > 19 > report Date
2020-06-12
Earnings History > 19 > date
2020-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.03
Earnings History > 19 > eps Estimate
-0.01
Earnings History > 19 > eps Difference
-0.02
Earnings History > 19 > surprise Percent
-200
Earnings History > 20 > period
2019-09-30
Earnings History > 20 > report Date
2019-11-26
Earnings History > 20 > date
2019-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.05
Earnings History > 20 > eps Estimate
-0.03
Earnings History > 20 > eps Difference
-0.02
Earnings History > 20 > surprise Percent
-66.6667
Earnings History > 21 > period
2019-06-30
Earnings History > 21 > report Date
2019-08-28
Earnings History > 21 > date
2019-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.051
Earnings History > 21 > eps Estimate
-0.02
Earnings History > 21 > eps Difference
-0.031
Earnings History > 21 > surprise Percent
-155
Earnings History > 22 > period
2019-03-31
Earnings History > 22 > report Date
2019-04-30
Earnings History > 22 > date
2019-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.03
Earnings History > 22 > eps Estimate
-0.01
Earnings History > 22 > eps Difference
-0.02
Earnings History > 22 > surprise Percent
-200
Earnings History > 23 > period
2018-09-30
Earnings History > 23 > report Date
2018-11-13
Earnings History > 23 > date
2018-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0027
Earnings History > 23 > eps Estimate
-0.01
Earnings History > 23 > eps Difference
0.0073
Earnings History > 23 > surprise Percent
73
Earnings History > 24 > period
2018-06-30
Earnings History > 24 > report Date
2018-08-22
Earnings History > 24 > date
2018-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.0275
Earnings History > 24 > eps Estimate
-0.01
Earnings History > 24 > eps Difference
-0.0175
Earnings History > 24 > surprise Percent
-175
Earnings History > 25 > period
2018-03-31
Earnings History > 25 > report Date
2018-05-29
Earnings History > 25 > date
2018-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.05
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2017-12-31
Earnings History > 26 > report Date
2018-02-03
Earnings History > 26 > date
2017-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.02
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.02
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2017-09-30
Earnings History > 27 > report Date
2017-11-27
Earnings History > 27 > date
2017-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.0029
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2017-06-30
Earnings History > 28 > report Date
2017-08-17
Earnings History > 28 > date
2017-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.0195
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-03-31
Earnings History > 29 > report Date
2017-05-30
Earnings History > 29 > date
2017-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0198
Earnings History > 29 > eps Estimate
-0.01
Earnings History > 29 > eps Difference
-0.0098
Earnings History > 29 > surprise Percent
-98
Earnings History > 30 > period
2016-09-30
Earnings History > 30 > report Date
2016-11-28
Earnings History > 30 > date
2016-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.0052
Earnings History > 30 > eps Estimate
-0.01
Earnings History > 30 > eps Difference
0.0152
Earnings History > 30 > surprise Percent
152
Earnings History > 31 > period
2016-06-30
Earnings History > 31 > report Date
2016-08-22
Earnings History > 31 > date
2016-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.21
Earnings History > 31 > eps Estimate
-0.01
Earnings History > 31 > eps Difference
-0.2
Earnings History > 31 > surprise Percent
-2000
Earnings History > 32 > period
2016-03-31
Earnings History > 32 > report Date
2016-06-01
Earnings History > 32 > date
2016-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-13.5857
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2015-09-30
Earnings History > 33 > report Date
2015-11-09
Earnings History > 33 > date
2015-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
1.0244
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2015-06-30
Earnings History > 34 > report Date
2015-08-24
Earnings History > 34 > date
2015-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-56.3573
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2015-03-31
Earnings History > 35 > report Date
2015-06-03
Earnings History > 35 > date
2015-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-34.6481
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATreasury Yields: Is now the right time to enter FUBO - 2025 Growth vs Value & Fast Entry and Exit Trade Plans baoquankhu1.vn
Read more →Recap Report: Is STRW stock influenced by commodity prices - New Guidance & Smart Investment Allocation Tips baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$700
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of Scinai Immunotherapeutics Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-2.6
EPS Estimate
0
EPS Difference
-2.6
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.